Almost all cancer therapies lead to a wide array of side effects, owing to the disruption of
normal physiological processes and alteration of immunological responses. Of these …

Mucositis is a common and feared complication of anticancer therapy that can affect up to
90% of certain populations of patients with cancer. Even seemingly uncomplicated …

Mucositis is a common complication of cancer therapy and can be a debilitating and dose-
limiting toxicity. Nearly all patients with head and neck cancer treated with radiotherapy …

Mucositis is one of the commonest complication of cancer treatment encountered during
chemotherapy & in head and neck radiation therapy. The degree of discomfort experienced …

The National Cancer Institute defines mucositis as a complication of some cancer therapies
characterised by inflammation of the mucosal surfaces of the digestive system, often seen as …

Mucositis induced by antineoplastic drugs is an important, dose-limiting, and costly side
effect of cancer therapy. The ulcerative lesions produced by mucotoxic chemoradiotherapy …

Mucositis is a general term that refers to the inflammatory reaction and shallow ulcerative
lesions which occur on the mucosal surfaces. It is not limited to the oral mucosa. It is a …

Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

The oral and gastrointestinal mucosa is frequently damaged during chemotherapy and
radiotherapy in patients with cancer, leading to a high incidence of mucositis (ie, oral …

Mucositis is an important toxicity to be aware of in anticancer therapy. It contributes to a
reduction in cure rates from cancer. Until recently, it has been poorly understood and …